This company is a specialty biopharmaceutical company that has established a drug development platform to actualize an orally administered, low-dose version of the drug interferon, which is a well characterized immune system modulator. Interferon serves as one of the most…
This company is a specialty biopharmaceutical company that develops drugs specifically for the acute-care hospital setting. The company has developed an intravenous calcium channel…
The company is a specialty biopharmaceutical company that focuses on the production of therapeutics for women’s health, specifically hormonal contraceptives, utilizing the company’s own dermal drug delivery system. The company’s products …
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
More than 50 innovative medical technology companies from around the world will present their company profiles to potential investors, partners and industry stakeholders at AdvaMed 2010: The MedTech Conference, being held October 18-20, 2010 in Washington, D.C.
Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.
An disorder frequently associated with ED is Peyronie’s disease.
LifeTech Capital invites you to their 1st Annual Miami Medical Investors Conference November 12th at the brand new JW Marriott Marquis Miami.
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
The medtech industry’s leading conference for face-to-face dialogue with top investors, large device companies, and the hottest emerging innovators.
Copyright © 2025 | WordPress Theme by MH Themes